Literature DB >> 9709944

Calcium-sensing by parathyroid glands in secondary hyperparathyroidism.

W G Goodman1, J D Veldhuis, T R Belin, A J Van Herle, H Juppner, I B Salusky.   

Abstract

Calcium-sensing by the parathyroids is abnormal in familial benign hypocalciuric hypercalcemia and in primary hyperparathyroidism (primary HPT), but the role of a calcium-sensing defect in uremic secondary hyperparathyroidism (secondary HPT) remains controversial. To study the regulation of PTH release by calcium, set point estimates were obtained using the four parameter model during in vivo dynamic tests of parathyroid gland function in 31 patients with secondary HPT, 8 patients with advanced secondary HPT studied shortly before undergoing parathyroidectomy (Pre-PTX), 3 patients with primary HPT, and 20 subjects with normal renal function (NL); the response to 2-h i.v. calcium infusions was also evaluated. Neither blood ionized calcium (iCa+2) levels nor the set point for calcium-regulated PTH release differed between secondary HPT and NL; iCa+2 levels and set point values were moderately elevated in Pre-PTX and markedly elevated in primary HPT. Compared with values obtained in NL, the lowest serum PTH levels achieved during calcium infusions, expressed as a percentage of pre-infusion values, were incrementally greater in secondary HPT, Pre-PTX, and primary HPT, whereas the slope of the relationship between iCa+2 and PTH, expressed as the natural logarithm (ln) of percent preinfusion values, decreased incrementally in secondary HPT, Pre-PTX, and primary HPT. The inhibitory effect of calcium on PTH release is blunted both in secondary HPT and primary HPT because of increases in parathyroid gland mass, but a calcium-sensing defect is a late, rather than early, consequence of renal secondary HPT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709944     DOI: 10.1210/jcem.83.8.4999

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

2.  Dermal Calcium Loss Is Not the Primary Determinant of Parathyroid Hormone Secretion during Exercise.

Authors:  Wendy M Kohrt; Pamela Wolfe; Vanessa D Sherk; Sarah J Wherry; Toby Wellington; Edward L Melanson; Christine M Swanson; Connie M Weaver; Rebecca S Boxer
Journal:  Med Sci Sports Exerc       Date:  2019-10       Impact factor: 5.411

3.  Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland.

Authors:  C David Bell; Sergio Vidal; Kalman Kovacs; Jennifer Anderson; Fabio Rotondo
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

4.  Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.

Authors:  P Chen; P Olsson Gisleskog; J J Perez-Ruixo; J Xiao; J Wilkins; A Narayanan; J P Gibbs; M Melhem
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-09-17

5.  A mathematical model of parathyroid gland biology.

Authors:  Gudrun Schappacher-Tilp; Alhaji Cherif; Doris H Fuertinger; David Bushinsky; Peter Kotanko
Journal:  Physiol Rep       Date:  2019-04

6.  The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.

Authors:  Xiaoer Zhang; Wenxin Xu; Tongyi Huang; Jingzhi Huang; Chunyang Zhang; Yutong Zhang; Xiaoyan Xie; Ming Xu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

Review 7.  The Molecular Basis of Calcium and Phosphorus Inherited Metabolic Disorders.

Authors:  Anna Papadopoulou; Evangelia Bountouvi; Fotini-Eleni Karachaliou
Journal:  Genes (Basel)       Date:  2021-05-13       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.